Board Meeting15 May 2026, 09:26 am
Transgene Biotek Board Meeting Scheduled for May 29, 2026
AI Summary
Transgene Biotek Ltd has announced a meeting of its Board of Directors on May 29, 2026, to consider and approve the audited financial results (standalone and consolidated) for the fourth quarter and financial year ended March 31, 2026. The meeting will also address any other business matters with the chair's permission.
Key Highlights
- Board meeting scheduled for May 29, 2026.
- Audited financial results for Q4 and FY26 to be considered.
- Standalone and consolidated results will be reviewed.
- Other business matters may be discussed.
Price Impact
More from TRABI